InvestorsHub Logo
Followers 840
Posts 121043
Boards Moderated 9
Alias Born 09/05/2002

Re: DewDiligence post# 1114

Tuesday, 06/20/2023 1:23:57 PM

Tuesday, June 20, 2023 1:23:57 PM

Post# of 1170
GERN submits Imetelstat NDA for treatment of transfusion-dependent anemia in adult patients with low-to-intermediate-1 risk myelodysplastic syndromes:

https://www.businesswire.com/news/home/20230620336071/en

This is an indication where BMY is seeking FDA approval for Reblozyl and where Reblozyl is already approved in the EU.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

57.051
0.011 (0.02%)
Volume: 8,104,674
Day Range: 56.29 - 57.39
Bid:
Ask:
Last Trade Time: 7:59:30 PM EST
Total Trades: 72,970
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BMY News